In vitro analysis of volume-reduced washed platelet concentrates stored in bicarbonated Ringer's solution containing

S Oikawa1, M Minegishi1, K Endo1

  • 1Japanese Red Cross Tohoku Block Blood Center, Sendai, Japan.

Vox Sanguinis
|February 27, 2016
PubMed

Insights

Volume-reduced washed platelet concentrates (PCs) stored in a novel solution maintained quality for 5 days. This innovative approach offers a safe alternative for transfusion patients, especially in pediatric settings.

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Biotechnology

Background:

  • Volume-reduced washed platelet concentrates (PCs) are crucial for preventing transfusion complications like circulatory overload and allergic reactions.
  • These specialized PCs are particularly needed for pediatric patients and individuals at risk of fluid overload.
  • Current storage methods require evaluation for optimized quality and safety.

Purpose of the Study:

  • To assess the in vitro quality of volume-reduced washed platelet concentrates (PCs) stored for 5 days.
  • To evaluate a novel acetate-free platelet additive solution (PAS) containing glucose and bicarbonate (BRS-A) with minimal residual plasma protein (<5%).
  • To compare the quality of PCs stored in BRS-A with conventional plasma storage.

Main Methods:

  • Platelet concentrates (PCs) from apheresis donations were divided into control (100% plasma) and test (volume-reduced, washed, BRS-A) units.
  • Test units were washed and stored in 90 ml of BRS-A, while control units were stored in 200 ml of plasma without washing.
  • In vitro properties, including pH, platelet concentration, glucose consumption, lactate production, hypotonic shock response, and activation marker expression (CD62P, CD42b), were monitored over 5 days.

Main Results:

  • Volume-reduced washed PCs achieved a twofold lower mean volume (91 ml) and removed >98% of plasma protein.
  • Initial mean platelet concentration in test units was twofold higher (20.5 × 10^11 /l) than in controls.
  • Test units maintained pH >7.0 for 5 days, with higher glucose consumption and lactate production, leading to glucose depletion by Day 3. Activation markers remained comparable between groups.

Conclusions:

  • The novel BRS-A solution effectively maintains the in vitro quality of volume-reduced washed platelets.
  • A 90-ml volume of BRS-A appears adequate for preserving platelet quality for at least 2 days, considering its pH buffering capacity.
  • This approach supports the development of safer and more effective platelet transfusion strategies.
Abstract

Related Concept Videos